Datavant acquires Aetion to broaden RWE platform

Health80 Views
Datavant acquires Aetion to broaden RWE platform

Information sharing know-how firm Datavant introduced it’s going to purchase Aetion, an organization centered on real-world proof in healthcare.

Aetion will be part of Datavant to supply an end-to-end real-world proof (RWE) platform, permitting healthcare and life sciences firms to reply to analysis questions in regards to the medical affect of therapies in improvement and in-market.

Davavant’s platform allows healthcare data to maneuver between organizations, together with greater than 70,000 hospitals and clinics.

Aetion offers RWE choices to biopharmaceutical firms, medical system producers, payers and regulators.

The businesses will leverage their capabilities to create an end-to-end providing on information discovery, linkage, privateness, curation and superior evaluation, permitting their ecosystem and life sciences companions to create analytics-based insights. 

The announcement comes after the launch of Datavant Join, powered by AWS Clear Rooms, which “facilitates cloud-first information discovery and analysis to speed up time to perception.”

By way of Datavant Join, information could be mixed with corresponding information sources. 

In line with the 2 firms, Aetion will improve the Datavant Join platform’s information discovery options, strengthen privateness assessments, and provides clients datasets and analytics.

As well as, the Aetion Proof Platform will probably be out there in AWS’ Market.

“Actual-world proof has reached an inflection level the place now we have to begin to make extra sense out of the information,” Arnaub Chatterjee, president and normal supervisor of  life sciences, ecosystem and public sector at Datavant, advised MobiHealthNews.

“By combining Datavant’s and Aetion’s complementary capabilities, we will probably be well-positioned to ship new instruments to find out information feasibility, querying, evaluation and finally, allow equitable entry to information. One of many issues I am most enthusiastic about is with the ability to give our clients a brand new means to have a look at information and use it to unravel actually complicated issues earlier than, throughout and after commercialization.”

THE LARGER TREND

Datavant expanded its collaboration with pharmaceutical firm Boehringer Ingelheim this month, to assist Boehringer’s RWE initiatives. 

The prolonged collaboration goals to leverage Datavant’s tokenization and information connectivity applied sciences to enhance medical improvement and provoke methods throughout 75 extra medical trials and a number of new molecular entities.

By making use of Datavant’s know-how throughout a broad portfolio of trials and launches, Boehringer Ingelheim goals to extend the combination of real-world information into drug improvement.

In 2023, Socially Decided partnered with Datavant to offer life sciences firms with information on social threat drivers to enhance well being fairness and affected person outcomes. 

In 2021, MindMed turned to Datavant to assist hyperlink its medical trial information with exterior proof from different medical trials and real-world information sources.

A yr earlier than, Datavant closed $40 million in Collection B funding. Transformation Capital led the rounds with participation from Johnson & Johnson Innovation, JJDC, Cigna Ventures and prior traders Roivant Sciences and Flex Capital.

That very same yr, Datavant acquired Ciox Well being in a deal valued at $7.0 billion. The mixed firm centered on bettering affected person outcomes and lowering prices by eradicating impediments to the safe well being information change. 

In 2023, Aetion collaborated with the FDA’s Oncology Middle of Excellence (OCE)

The OCE used Aetion’s Proof Platform to search out and analyze real-world information sources that may very well be used for most cancers prevention, medical care, diagnostics and therapy analysis. 

The collaboration assessed real-world endpoints, measured healthcare disparities, and evaluated causal inference strategies. The analysis was scheduled to proceed till 2027. 

In 2022, Aetion acquired Duplicate Analytics, which gave Aetion new capabilities in artificial RWE. The announcement got here lower than a yr after Aetion secured a $110 million Collection C funding spherical led by Warburg Pincus. 

Leave a Reply

Your email address will not be published. Required fields are marked *